Minjie Wang

Minjie Wang

Auto-generated profile, based on publicly available information

Minjie Wang

Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2022 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
MZMengdi Zhang
Mengdi Zhang
YHYuxia Hu
Yuxia Hu
FYFan Yang
Fan Yang
JZJingwen Zhang
Jingwen Zhang
JZJianxin Zhang
Jianxin Zhang
FCFuhou Chang
Fuhou Chang
Background: The main causes of lung cancer are smoking, environmental pollution and genetic susceptibility. It is an indisputable fact that PAHs are related to lung cancer, and benzo(a) pyrene is a representative of PAHs. The purpose of the current investigation was to investigate the interaction between AhR and HIF-1 signaling pathways in A549 cells, which provide some experimental basis for scientists to find drugs that block AhR and HIF-1 signaling pathway to prevent and treat cancer. Methods: This project adopts the CYP1A1 signaling pathways and the expression of CYP1B1 is expressed as a measure of AhR strength index. The expression of VEGF and CAIX volume as a measure of the strength of the signal path HIF-1 indicators. Through the construction of plasmid vector, fluorescence resonance energy transfer, real-time quantitative PCR, western blotting and immunoprecipitation, the interaction between AhR signaling pathway and HIF-1 signaling pathway was observed. Results: BaP can enhance the binding ability of HIF-1α protein to HIF-1β/ARNT in a dose-dependent manner without CoCl2. However, the binding ability of AhR protein to HIF-1β/ARNT is inhibited by HIF-1α signaling pathway in a dose-dependent manner with CoCl2. Conclusion: It is shown that activation of the AhR signaling pathway does not inhibit the HIF-1α signaling pathway, but activation of the HIF-1α signaling pathway inhibits the AhR signaling pathway.

23 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CZChaocai Zhang
Chaocai Zhang
MWMinjie Wang
Minjie Wang
FJFenghu Ji
Fenghu Ji
YPYizhong Peng
Yizhong Peng
BWBo Wang
Bo Wang
HZHongyang Zhao
Hongyang Zhao
Introduction. Glioblastoma (GBM) is one of the most frequent primary intracranial malignancies, with limited treatment options and poor overall survival rates. Alternated glucose metabolism is a key metabolic feature of tumour cells, including GBM cells. However, due to high cellular heterogeneity, accurately predicting the prognosis of GBM patients using a single biomarker is difficult. Therefore, identifying a novel glucose metabolism‐related biomarker signature is important and may contribute to accurate prognosis prediction for GBM patients. Methods. In this research, we performed gene set enrichment analysis and profiled four glucose metabolism‐related gene sets containing 327 genes related to biological processes. Univariate and multivariate Cox regression analyses were specifically completed to identify genes to build a specific risk signature, and we identified ten mRNAs (B4GALT7, CHST12, G6PC2, GALE, IL13RA1, LDHB, SPAG4, STC1, TGFBI, and TPBG) within the Cox proportional hazards regression model for GBM. Results. Depending on this glucose metabolism‐related gene signature, we divided patients into high‐risk (with poor outcomes) and low‐risk (with satisfactory outcomes) subgroups. The results of the multivariate Cox regression analysis demonstrated that the prognostic potential of this ten‐gene signature is independent of clinical variables. Furthermore, we used two other GBM databases (Chinese Glioma Genome Atlas (CGGA) and REMBRANDT) to validate this model. In the functional analysis results, the risk signature was associated with almost every step of cancer progression, such as adhesion, proliferation, angiogenesis, drug resistance, and even an immune‐suppressed microenvironment. Moreover, we found that IL31RA expression was significantly different between the high‐risk and low‐risk subgroups. Conclusion. The 10 glucose metabolism‐related gene risk signatures could serve as an independent prognostic factor for GBM patients and might be valuable for the clinical management of GBM patients. The differential gene IL31RA may be a potential treatment target in GBM.

8 July 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MWMinjie Wang
Minjie Wang
ZZZijie Zhou
Zijie Zhou
XWXuan Wang
Xuan Wang
CZChaocai Zhang
Chaocai Zhang
XJXiaobing Jiang
Xiaobing Jiang
Due to the negligence of the complex tumor immune microenvironment, traditional treatment for glioblastoma has reached its limitation and cannot achieve a satisfying outcome in the past decade. The emergence of immunotherapy based on the theory of cancer-immunity cycle has brought a new dawn to glioblastoma patients. However, the results of most phase II and phase III clinical trials are not optimistic due to the simple focus on T cells activation rather than other immune cells involved in anti-tumor immunity. NK cells play a critical role in both innate and adaptive immunity, having the ability to coordinate immune response in inflammation, autoimmune disease and cancer. They are expected to cooperate with T cells to maximize the anti-tumor immune effect and have great potential in treating glioblastoma. Here, we describe the traditional treatment methods and current immunotherapy strategies for glioblastoma. Then, we list a microenvironment map and discuss the reasons for glioblastoma inhibitory immunity from multiple perspectives. More importantly, we focus on the advantages of NK cells as potential immune regulatory cells and the ways to maximize their anti-tumor immune effect. Finally, our outlook on the directions and potential applications of NK cell-based therapy combining with the advance technologies is presented. This review depicts NK cell awakening as the precondition to unleash the cancer-immunity cycle against glioblastoma and elaborate this idea from biology to clinical treatment.

24 May 2022 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
HYHao Yu
Hao Yu
YPYizhong Peng
Yizhong Peng
ZWZhipeng Wu
Zhipeng Wu
MWMinjie Wang
Minjie Wang
XJXiaobing Jiang
Xiaobing Jiang
Original Article MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis Hao Yu, Yizhong Peng, Zhipeng Wu, Minjie Wang, Xiaobing Jiang

19 June 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
FCFeng Chen
Feng Chen
MWMin-Jie Wang
Min-Jie Wang
JLJia Li
Jia Li
CYCui-E Yan
Cui-E Yan
XHXiaohong Han
Xiaohong Han
JQJun Qi
Jun Qi

16 August 2022 in Frontiers in Endocrinology
Verified
Journal Article
Open access
LJLichao Jin
Lichao Jin
XZXiwei Zhang
Xiwei Zhang
SNSong Ni
Song Ni
DYDangui Yan
Dangui Yan
MWMinjie Wang
Minjie Wang
CAChangming An
Changming An
Background: Medullary thyroid cancer (MTC) can only be cured by surgery, but the management of lateral lymph nodes is controversial, especially for patients with cN0+cN1a. To address this challenge, we developed a multivariate logistic regression model to predict lateral lymph node metastases (LNM).Methods: We retrospectively collected clinical data from 124 consecutive MTC patients who underwent initial surgery at our institution. The data of 82 patients (from 2010 to 2018) and 42 patients (from January 2019 to November 2019) were used as the training set for building the model and as the test set for validating the model, respectively.Results: In the training group, the multivariate analyses indicated that male and MTC patients with higher preoperative basal calcitonin levels were more likely to have lateral LNM (P = 0.007 and 0.005, respectively). Multifocal lesions and suspected lateral LNM in preoperative ultrasound (US) were independent risk factors (P = 0.032 and 0.002, respectively). The identified risk factors were incorporated into a multivariate logistic regression model to generate the nomogram, which showed good discrimination (C-index = 0.963, 95% confidence interval [CI]: 0.9286–0.9972). Our model was validated with an excellent result in the test set and even superior to the training set (C-index = 0.964, 95% CI: 0.9121–1.000).Conclusion: Higher preoperative basal calcitonin level, male sex, multifocal lesions, and lateral lymph node involvement suspicion on US are risk factors for lateral LNM. Our model and nomogram will objectively and accurately predict lateral LNM in patients with MTC.